ANTIBACTERIAL ACTIVITY OF MEROPENEM AND SELECTED COMPARATIVE AGENTS AGAINST ANAEROBIC-BACTERIA AT 7 NORTH-AMERICAN CENTERS

The antibacterial activity of meropeneni and comparative agents agains t approximately 1,000 anaerobes was determined using the disk dilution methods recommended by the National Committee for Clinical Laboratory Standards (NCCLS). The organisms represented 27 species of six genera and included the most common pathogens. Meropenem and imipenem were t he most active drugs and were comparable in overall activity, generall y exhibiting an MIC90 of less-than-or-equal-to 1 mug/mL. In contrast, the MICs of cefoxitin, clindamycin, and metronidazole were 32, 16, and 2 mug/mL, respectively. Meropenem was two- to fourfold more active th an imipenem against selected Bacteroides species, Clostridium species, and Fusobacterium species. At a concentration of 1 mug/mL, meropenem was more active than imipenem against cefoxitin-resistant Bacteroides fragilis or Bacteroides thetaiotaomicron. At a concentration of less-t han-or-equal-to 0.5 mug/mL, meropenem was more active than imipenem ag ainst clindamycin-resistant Bacteroides distasonis. At a concentration of 2 mug/mL, meropenem was more active than imipenem against cefoxiti n-resistant or clindamycin-resistant Clostridium difficile. Thus, mero penem's high potency and broad-spectrum activity against common, rare, and drug-resistant anaerobes confirms its utility in the treatment of mixed anaerobic and aerobic infections.